Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Awesome for busy people with busy schedules
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
Retatrutide is an experimental triple-agonist weight-loss and diabetes drug developed by Eli Lilly that targets GLP-1, GIP, and glucagon receptors
Use new sterile insulin syringes for each administration
Do not freeze the vials, as freezing and thawing could potentially precipitate ingredients or compromise the integrity of the container
US$ 26.14
US$ 28.19
US$ 29.81
US$ 22.62
US$ 28.90
US$ 20.24
US$ 26.55
US$ 20.09
US$ 25.10